Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...

A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

On its website, Empower advertises tirzepatide and semaglutide injections mixed with B vitamins ... the boundaries of federal and state laws and compound these therapies only for individualized ...

Several years ago, a GLP-1-like compound was discovered in the saliva of the Gila monster lizard that is resistant to breakdown, which led to development of GLP-1-like pharmaceuticals. In 2017 Ozempic ...

"We are deeply disappointed that the (court) misapprehended or failed to take into consideration the clear and convincing evidence that demonstrates that the manufactured supply of semaglutide is ...

The latest discovery in obesity medicine will be available in less invasive creams and patches, known as transdermal drug ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.